Clinical Trial Update: Meditation-Based Stress Reduction in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating meditation-based stress reduction for rheumatoid arthritis has completed. The update summarizes the study results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED